However, analysis of immune cell subsets cultured with anti–PD-1–resistant tumor cells in the presence of a pan-LPAR inhibitor revealed that some immunosuppressive populations are affected by LPA, as pan-LPAR blockade increased suppressive CD4+ Tregs and decreased effector CD4+ cells. This evidence concerns the gene CD4 and neoplasm.